Walgreens CEO Tim Wentworth at #JPM24 (Brian Benton Photography)

April 25, 2024 12:01 AM EDT

Walgreens will build out specialty pharmacy business, leaning into drug and therapy services

Lydia Ramsey Pflanzer

Deputy Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Sanofi makes $470M move for Vigil's Alzheimer's drug, while another asset returns to Amgen

Post-Hoc: AI bio needs to heed the overhyped history of CRISPR

FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

FDA asks Covid vaccine makers to add more myocarditis data to labels

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?